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Microparticles (MP) have gained increasing attention as biomark-
ers for various diseases. First described as platelet dust, MP were
regarded as unspeciﬁc debris [1]. However, it has become appar-
ent that cell derived MP or ectosomes represent a novel route of
horizontal communication between cells. MP are between 100–
1000 nm in size and generated through cell membrane shedding
(ectocytosis), a process that can be triggered by the activation of
the complement C5b-9 complex, as shown for platelet derived
MP, or by inhibition of ﬂippase activity through Ca2+ inﬂux, which
facilitates collapse of the plasma membrane phospholipids asym-
metry [2,3]. This process involves regulated sorting of membrane
proteins into the shed MP and ﬂipping of phosphatidylserine
from the inner to the outer membrane during cellular activation
or early apoptosis [2,4,5]. MP resemble their parental cells on a
smaller scale and share with them many characteristics, such
as surface receptors, integral membrane and certain cytosolic
proteins, some mRNAs and miRNAs [5]. Notably, earlier studies
focused mostly on platelet MP [1,2,4–12], except for more recent
studies on endothelial cell and leukocyte derived MP in cardio-
vascular diseases [13]. An elevation of platelet (CD41+) MP in
the blood indicates the presence of inﬂammatory disease or its
progression. Thus, an increase of platelet MP in synovial ﬂuid or
blood plasma is found in rheumatoid arthritis [8], HIV [9], the
polycystic ovary syndrome [11], malaria [10] or inﬂammation
in general [12]. Importantly, MP are not simply surrogate
markers of platelet activation or disease activity, but can also
modulate neighbouring cells, e.g., by transferring functional cell
surface receptors that may trigger novel pathways in the recipi-
ent cell, by exchange of mRNA or miRNA, or by transfer of antigen
via MHC class II molecules and other surface molecules [13]. For
example, the phenotype of cells deﬁcient in CXCR4 and CD81 was
rescued by transfer of MP carrying these surface receptorsJournal of Hepatology 20
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non-alcoholic fatty liver; MP, microparticle.[5,7,14]. Moreover, recent studies have demonstrated that apart
from platelets, other cells release functional MP upon activation
or early apoptosis, such as from T cells that via transfer of the
metalloproteinase inducer CD147 (EMMPRIN) induce ﬁbrolytic
activation of hepatic stellate cells [15], or from leukocytes of
cirrhotic patients that affect microvessels by compromising
vasoconstrictor responses and decreasing systemic blood pres-
sure [16] (Fig. 1).Microparticles as liver disease biomarkers
As outlined before, platelet MP were considered a shared marker
of disease activity, precluding their utility as disease-speciﬁc bio-
marker. Only recently, the concept and technology to quantitate
different MP populations from plasma or serum have been
established, allowing to assess the presumed extent to which a
speciﬁc (immune cell) compartment is activated in a given
disease. Notably, this is illustrated in chronic hepatitis C (CHC),
and non-alcoholic fatty liver (NAFLD) [15,17], which show dis-
ease-speciﬁc MP proﬁles/signatures. Thus patients with CHC, a
disease that is dominated by CD4+ and CD8+ hepatic T-cell inﬁl-
tration, have primarily elevated circulating CD4+ and CD8+ T cell
MP, whereas patients with NAFLD, a disease that is characterized
by invariant NKT (iNKT) cells and CD14+ macrophages, mono-
cytes, and dendritic cells (which play a key role in fatty tissue
inﬂammation and the metabolic syndrome) have a unique signa-
ture of circulating iNKT and CD14+ MP [15,17]. Notably, these MP
elevations correlate with the extent of histological inﬂammation
in paired biopsies, though this correlation is not perfect, likely
due to the biopsy’s sampling variability rather than incorrectness
of MP diagnostics.
However, it must be stressed that exact MP functional studies
and diagnostics heavily depend on proper puriﬁcation and charac-
terization ofMP fractions,which have not been done inmany prior
studies. Several groups showed that MP are annexin V positive on
their external surface, since they cannot maintain the phospho-
lipid asymmetry of the plasma membrane, which requires energy
and various enzymes such as a phospholipid ﬂippase, which is lar-
gely absent or inactive in MP [4,18]. Upon cell activation resulting
in increased intracellular Ca2+, the ﬂippase becomes inactivated
and a ﬂoppase activated, leading to collapse of the energy consum-
ing lipid asymmetry and resulting in membrane budding and
release of annexin V positive MP [4]. Generation of annexin V12 vol. 57 j 1144–1146
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Fig. 1. Microparticles: origin, characteristics and biological effects. (A) Characteristics of exosomes, microparticles (MP), apoptotic bodies and living cells regarding
phosphatidylserine (PS, annexin V) orientation within their membranes. PS is found preferentially in the inner leaﬂet of the cell membrane of living cells. Exosomes, MP and
apoptotic bodies are incapable tomaintain the asymmetry of their bilayer cellmembranedue to lack of ﬂippase activity, permitting their detectionwith antibodies to annexinV
or dye labelled recombinant annexin V in FACS analysis. Exosomes are formed intracellularly, storedwithin endosomal vesicles and released by an energy-consuming process,
while MP are released by plasma membrane blebbing resulting in vesicles equipped with parts of the parental cell membrane. (B) Simpliﬁed overview of the most recently
studiedcell typesandaccompanyingMPpopulationsas found in theperipheralblood [4,8,10,11,15–17].MPare released frommultiple cell typesand fusewithplasmamembranes
ofother cells, includinghepatic stellateandvascularendothelial cells. Insert (C) showshowcytosolicproteins,mRNA,microRNAorother components stored in the lumenofMPcan
be transferred to a recipient cell (i–iii). In addition, membrane fusion can transfer receptors fromMP altering receptor-mediated signal transduction in the recipient cells.
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positive MP during early apoptosis may follow another yet ill-
deﬁned mechanism during generation of apoptotic bodies [4].
However, apoptotic bodies are no MP. They are characterized by
a larger diameter (>1000 nm) and contain nuclear material [4].
Suchmaterial sediments at 10,000g as opposed toMP sedimenting
between 10,000 and 100,000g [8,15,17]. Another ‘‘contaminant’’ of
shedded vesicles are exosomes, a class of phospholipid bilayer
vesicles that are stored intracellularly and are either annexin V
negative or only slightly positive [13]. They are smaller in size
(<100 nm) and sediment at 100,000g in sucrose gradients [4,6].
All these ‘undesired’ particles have to be removed physically by
differential centrifugation or gated out during the process of ﬂuo-
rescent-activated cell sorting (FACS). Only such rigorous separa-
tion permits an exact MP quantiﬁcation [15–17].Prospects
Based on current knowledge, we suggest that circulating MP will
likely become novel, highly attractive biomarkers for cell and dis-
ease speciﬁc (immune) activation, and that MP promise to
become useful markers for diagnosis and especially monitoring
of acute and chronic liver diseases. Importantly, MP proﬁling
may allow for a better on-target, e.g., inﬂammatory cell-speciﬁc
assessment of therapies directed to subsets of cells that are
involved in disease pathogenesis, such as certain T cells in viral
or autoimmune hepatitis, endothelial cells in cirrhosis, or iNKT
cells and macrophages in NASH. To this aim, state of the art
methodology for MP isolation and quantiﬁcation is mandatory.
Finally, the biological properties of MP as cell–cell signaling
modalities may be exploited for an improved cell-speciﬁc deliv-
ery of drugs and biologicals in liver and other diseases.Conﬂict of interest
The authors declared that they do not have anything to disclose
regarding funding or conﬂict of interest with respect to this
manuscript.Financial support
The underlying research reported in the study was funded by the
NIH Institutes of Health.
Acknowledgements
This work was supported by NIDDK Grant R21 DK075857-01A2
to D.S. and DFG fellowship Grant KO4103/1-1 to M.K. Part of this1146 Journal of Hepatology 2012work was presented as oral presentation by M.K. during the EASL
annual meeting 2011 in Berlin, Germany, and as poster at DDW
2011, Chicago, USA.
References
[1] Wolf P. The nature and signiﬁcance of platelet products in human plasma. Br
J Haematol 1967;13:269–288.
[2] Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause
release of membrane vesicles from the platelet surface that are enriched in
the membrane receptor for coagulation factor Va and express prothrombin-
ase activity. J Biol Chem 1988;263:18205–18212.
[3] Morel O, Jesel L, Freyssinet JM, Toti F. Cellular mechanisms underlying the
formation of circulating microparticles. Arterioscler Thromb Vasc Biol
2011;31:15–26.
[4] Simak J, Gelderman MP. Cell membrane microparticles in blood and blood
products: potentially pathogenic agents and diagnostic markers. Transfus
Med Rev 2006;20:1–26.
[5] Beyer C, Pisetsky DS. The role of microparticles in the pathogenesis of
rheumatic diseases. Nat Rev Rheumatol 2010;6:21–29.
[6] Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets
release two types of membrane vesicles: microvesicles by surface shedding
and exosomes derived from exocytosis of multivesicular bodies and alpha-
granules. Blood 1999;94:3791–3799.
[7] Rozmyslowicz T, Majka M, Kijowski J, et al. Platelet- and megakaryocyte-
derived microparticles transfer CXCR4 receptor to CXCR4-null cells and
make them susceptible to infection by X4-HIV. AIDS 2003;17:33–42.
[8] Boilard E, Nigrovic PA, Larabee K, et al. Platelets amplify inﬂammation in
arthritis via collagen-dependent microparticle production. Science 2010;
327:580–583.
[9] Corrales-Medina VF, Simkins J, Chirinos JA, et al. Increased levels of platelet
microparticles in HIV-infected patients with good response to highly active
antiretroviral therapy. J Acquir Immune Deﬁc Syndr 2010;54:217–218.
[10] Pankoui Mfonkeu JB, Gouado I, Fotso Kuate H, et al. Elevated cell-speciﬁc
microparticles are a biological marker for cerebral dysfunctions in human
severe malaria. PLoS One 2010;5:e13415.
[11] Koiou E, Tziomalos K, Katsikis I, et al. Circulating platelet-derived micro-
particles are elevated in women with polycystic ovary syndrome diagnosed
with the 1990 criteria and correlate with serum testosterone levels. Eur J
Endocrinol 2011;165:63–68.
[12] Ripoche J. Blood platelets and inﬂammation: their relationship with liver
and digestive diseases. Clin Res Hepatol Gastroenterol 2011;35:353–357.
[13] Mause SF, Weber C. Microparticles: protagonists of a novel communication
network for intercellular information exchange. Circ Res 2010;107:
1047–1057.
[14] Fritzsching B, Schwer B, Kartenbeck J, et al. Release and intercellular transfer
of cell surface CD81 via microparticles. J Immunol 2002;169:5531–5537.
[15] Kornek M, Popov Y, Libermann TA, Afdhal NH, Schuppan D. Human T cell
microparticles circulate in blood of hepatitis patients and induce ﬁbrolytic
activation of hepatic stellate cells. Hepatology 2011;53:230–242.
[16] Rautou PE, Bresson J, Sainte-Marie Y, et al. Abnormal Plasma Microparticles
Impair Vasoconstrictor Responses in Patients with Cirrhosis. Gastroenterol-
ogy 2012;143:166–176.e166.
[17] Kornek M, Lynch M, Mehta SH, et al. Circulating Microparticles as Disease-
Speciﬁc Biomarkers of Severity of Inﬂammation in Patients with Hepatitis C
or Nonalcoholic Steatohepatitis. Gastroenterology 2012;143:448–458.
[18] Leventis PA, Grinstein S. The distribution and function of phosphatidylserine
in cellular membranes. Annu Rev Biophys 2010;39:407–427.vol. 57 j 1144–1146
